fair enough - I think manufacturing shouldn’t be an issue. It clearly has the advantage in that area. I think it’s more the logistics and supply chain of the drug that will make it tricky to commercialise. It has a longer half life but it is still time sensitive.
Personally, it’s not something that I know too much about but that would definitely be something Pharma companies will look for as well as the manufacturing.
- Forums
- ASX - By Stock
- CU6
- Research/Valuation
Research/Valuation, page-5
-
-
- There are more pages in this discussion • 659 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CU6 (ASX) to my watchlist
(20min delay)
|
|||||
Last
$8.40 |
Change
-0.330(3.78%) |
Mkt cap ! $2.742B |
Open | High | Low | Value | Volume |
$8.62 | $8.68 | $8.35 | $4.178M | 493.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
14 | 5473 | $8.39 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$8.41 | 1626 | 13 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 3777 | 8.390 |
6 | 2331 | 8.380 |
10 | 7699 | 8.370 |
11 | 9372 | 8.360 |
7 | 3221 | 8.350 |
Price($) | Vol. | No. |
---|---|---|
8.400 | 1346 | 9 |
8.410 | 3239 | 11 |
8.420 | 2288 | 11 |
8.430 | 966 | 7 |
8.440 | 338 | 2 |
Last trade - 13.22pm 04/10/2024 (20 minute delay) ? |
Featured News
CU6 (ASX) Chart |